Enter inventor name

Indianapolis, IN, United States of America

Warren Jaye Porter

This inventor holds 33 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Eli Lilly and Company, Athena Neurosciences, Inc., Elan Pharmaceuticals, Inc.. Active years: 2000-2016.

USPTO Granted Patents = 33

% Patents Active = 39.4

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 9.3

ph-index = 7

Forward Citations = 205(Granted Patents)

Company Filing History:

13 out of 4,507

Eli Lilly and Company

patents

6 out of 35

Athena Neurosciences, Inc.

patents

3 out of 202

Elan Pharmaceuticals, Inc.

5. 19 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2016

Loading Chart...

Areas of Expertise:

Tetrahydropyrrolothiazine Compounds

Azepine Derivatives

Cycloalkyl Compounds

Lactam Compounds

Lactone Compounds

Beta-Amyloid Peptide

Heterocyclic Compounds

Deoxyamino Acid Compounds

Pharmaceutical Compositions

Gamma-Secretase Inhibitors

AMPA Receptor Antagonist

N-(Aryl/Heteroaryl) Amino Acid Derivatives

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9469632 - [object Object] (2016-10-18),

2. 8889856 - Tetrahydropyrrolothiazine compounds (2014-11-18),

3. 8772282 - Tetrahydropyrrolothiazine compounds (2014-07-08),

4. 8765960 - 6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist (2014-07-01),

5. 8188069 - Azepine derivatives as gamma-secretase inhibitors (2012-05-29),

6. 7390801 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2008-06-24),

7. 6958330 - Polycyclic α-amino-ε-caprolactams and related compounds (2005-10-25),

8. 6951854 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-10-04),

9. 6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-06-14),

10. 6888022 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-05-03),

11. 6861558 - Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis (2005-03-01),

12. 6849650 - Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds (2005-02-01),

13. 6838455 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds (2005-01-04),

14. 6774125 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds (2004-08-10),

15. 6683075 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use (2004-01-27),

Title: Spotlight on Inventor Warren Jaye Porter

Introduction:

Warren Jaye Porter, a distinguished inventor based in Indianapolis, IN, has made significant contributions to the field of pharmaceuticals with a total of 33 patents to his name. His innovative spirit and dedication to research have led to groundbreaking discoveries in the industry.

Latest Patents:

1. TARP γ8 Dependant AMPA Receptor Antagonist: Porter's patent describes a novel compound that acts as an AMPA receptor antagonist, paving the way for potential advancements in neuropharmacology.

2. Tetrahydropyrrolothiazine Compounds: The invention of compounds with unique properties opens up possibilities for the development of new pharmaceuticals, enhancing the treatment options available to patients.

Career Highlights:

Porter has left an indelible mark on renowned companies such as Eli Lilly and Company, where his expertise and innovative thinking have been instrumental in driving scientific progress and product development in the pharmaceutical sector. His prolific career is a testament to his unwavering commitment to excellence in research and innovation.

Collaborations:

Throughout his career, Porter has had the privilege of working alongside talented individuals who share his passion for innovation. Collaborators like Lee H Latimer and Jon Kevin Reel have not only enriched his professional journey but have also contributed to the success of numerous projects and patents.

Conclusion:

Warren Jaye Porter's prolific career as an inventor and his numerous patents stand as a testament to his exceptional talent and dedication to advancing pharmaceutical research. His groundbreaking contributions have undoubtedly made a lasting impact on the industry, showcasing his unwavering commitment to innovation and scientific excellence.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]